National News
NAFDAC halts Artemether/Lumefantrine registration

The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
FCT News2 days ago
NAWOJ FCT Champions Women’s achievements, gender parity
-
FCT News2 days ago
IWD 2025: NUJ FCT Council honors Women’s Contributions, leadership roles (Photos)
-
News1 day ago
Niger NUJ Council congratulates Women on International Women’s Day
-
News1 day ago
FG to hold summit on Integrated Diagnostic Services
-
News1 day ago
IWD 2025: Farmer Bago felicitates with Nigeria Women
-
Sports1 day ago
Nigeria’s Dr. Ademola elected as 1st Vice President of west African Rugby union
-
National News2 days ago
Electoral process: INEC commited to encouraging women participation
-
News5 hours ago
Over 6,000 young people attend ‘Pacesetters’ Conference to build leadership, patriotism